South Korea · Delayed Price · Currency is KRW Bioneer Statistics
Total Valuation
Bioneer has a market cap or net worth of KRW 283.91 billion. The enterprise value is 317.78 billion.
| Market Cap | 283.91B |
| Enterprise Value | 317.78B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioneer has 25.81 million shares outstanding. The number of shares has increased by 0.81% in one year.
| Current Share Class | 25.81M |
| Shares Outstanding | 25.81M |
| Shares Change (YoY) | +0.81% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 18.03% |
| Owned by Institutions (%) | 4.00% |
| Float | 21.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.92 |
| EV / EBITDA | 21.94 |
| EV / EBIT | 50.96 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.00 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 7.36 |
| Debt / FCF | -11.04 |
| Interest Coverage | 1.37 |
Financial Efficiency
Return on equity (ROE) is -1.64% and return on invested capital (ROIC) is -2.97%.
| Return on Equity (ROE) | -1.64% |
| Return on Assets (ROA) | 1.05% |
| Return on Invested Capital (ROIC) | -2.97% |
| Return on Capital Employed (ROCE) | 2.12% |
| Weighted Average Cost of Capital (WACC) | 3.27% |
| Revenue Per Employee | 882.35M |
| Profits Per Employee | -17.02M |
| Employee Count | 392 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, Bioneer has paid 6.96 billion in taxes.
| Income Tax | 6.96B |
| Effective Tax Rate | 211.73% |
Stock Price Statistics
The stock price has decreased by -21.76% in the last 52 weeks. The beta is 0.37, so Bioneer's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -21.76% |
| 50-Day Moving Average | 7,064.20 |
| 200-Day Moving Average | 10,569.50 |
| Relative Strength Index (RSI) | 75.42 |
| Average Volume (20 Days) | 639,515 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioneer had revenue of KRW 345.88 billion and -6.67 billion in losses. Loss per share was -257.51.
| Revenue | 345.88B |
| Gross Profit | 264.99B |
| Operating Income | 6.24B |
| Pretax Income | 3.29B |
| Net Income | -6.67B |
| EBITDA | 14.48B |
| EBIT | 6.24B |
| Loss Per Share | -257.51 |
Balance Sheet
The company has 86.28 billion in cash and 106.58 billion in debt, with a net cash position of -20.30 billion or -786.46 per share.
| Cash & Cash Equivalents | 86.28B |
| Total Debt | 106.58B |
| Net Cash | -20.30B |
| Net Cash Per Share | -786.46 |
| Equity (Book Value) | 217.58B |
| Book Value Per Share | 7,889.52 |
| Working Capital | 74.86B |
Cash Flow
In the last 12 months, operating cash flow was -4.54 billion and capital expenditures -5.12 billion, giving a free cash flow of -9.66 billion.
| Operating Cash Flow | -4.54B |
| Capital Expenditures | -5.12B |
| Depreciation & Amortization | 8.25B |
| Net Borrowing | -3.39B |
| Free Cash Flow | -9.66B |
| FCF Per Share | -374.13 |
Margins
Gross margin is 76.61%, with operating and profit margins of 1.80% and -1.93%.
| Gross Margin | 76.61% |
| Operating Margin | 1.80% |
| Pretax Margin | 0.95% |
| Profit Margin | -1.93% |
| EBITDA Margin | 4.19% |
| EBIT Margin | 1.80% |
| FCF Margin | n/a |
Dividends & Yields
Bioneer does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.81% |
| Shareholder Yield | -0.81% |
| Earnings Yield | -2.35% |
| FCF Yield | -3.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioneer has an Altman Z-Score of 3 and a Piotroski F-Score of 5.
| Altman Z-Score | 3 |
| Piotroski F-Score | 5 |